Biotest AG
DUS:BIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biotest AG
DUS:BIO
|
DE |
|
T
|
TX Group AG
F:TAMN
|
CH |
|
S
|
Stryker Corp
XBER:SYK
|
US |
|
Wynn Resorts Ltd
F:WYR
|
US |
|
Volta Metals Ltd
F:D0W
|
CA |
|
P
|
Panasonic Holdings Corp
F:MATA
|
JP |
|
N4 Pharma PLC
F:0GO
|
UK |
|
S
|
Sumitomo Realty & Development Co Ltd
DUS:RL2
|
JP |
|
R
|
Rigolleau SA
BCBA:RIGO
|
AR |
|
I
|
Inogen Inc
F:6IO
|
US |
|
A
|
Allgeier SE
F:AEIN
|
DE |
|
I
|
Industrial and Commercial Bank of China Ltd
XBER:ICK
|
CN |
|
A
|
Accenture PLC
F:CSA
|
IE |
|
H
|
Heidelberg Pharma AG
XHAM:HPHA
|
DE |
|
D
|
Deere & Co
XMUN:DCO
|
US |
|
UFP Technologies Inc
F:UFP
|
US |
|
B
|
BYD Co Ltd
XMUN:BY6
|
CN |
|
F
|
Ford Motor Co
BMV:F
|
US |
|
Veidekke ASA
F:VK4
|
NO |
|
Schindler Holding AG
F:SHR
|
CH |
|
H
|
Heidelberg Materials AG
MIL:1HEI
|
DE |
|
Healthcare Realty Trust Inc
F:HT0
|
US |
|
L
|
Lowe's Companies Inc
F:LWE
|
US |
|
G
|
Groep Brussel Lambert NV
F:EAI
|
BE |
Bankruptcy Probability
Biotest AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biotest AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Biotest AG
XETRA:BIO
|
1.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biotest AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biotest AG has total debt of 639.8m EUR. This includes both short-term (0 EUR) and long-term (639.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
